Text Size
55 studies found for:    Open Studies | "Prostatic Hyperplasia"

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Unknown † A 20-Week Study of a New Treatment for Men With Benign Prostatic Hyperplasia (BPH).
Condition: Prostatic Hyperplasia
Intervention: Drug: ML-04A
2 Recruiting Safety and Efficacy of 0.5mg Dutasteride and 0.4mg Tamsulosin Combination Once Daily for Six Months for Benign Prostatic Hyperplasia
Condition: Prostatic Hyperplasia
Intervention: Drug: Dutasteride/Tamsulosin
3 Unknown † The Effectiveness of Saw Palmetto and Sanmiaoshan on Benign Prostatic Hyperplasia in Chinese Patients
Conditions: Prostatic Hyperplasia;   Adrenergic Alpha-Antagonists
Intervention: Drug: Saw palmetto and sanmiaoshan capsule
4 Not yet recruiting Prostate Artery Embolization With Embosphere Microspheres Compared to TURP for Benign Prostatic Hyperplasia
Condition: Benign Prostatic Hyperplasia
Interventions: Device: Embosphere Microspheres;   Procedure: TURP
5 Recruiting Comparison Between Alpha Blocker Monotherapy and 5ARI Monotherapy Following Combination Therapy in Benign Prostatic Hyperplasia (BPH)
Condition: Benign Prostatic Hyperplasia
Interventions: Drug: combination therapy;   Drug: alpha blocker monotherapy;   Drug: 5 alpha reductase inhibitor monotherapy
6 Unknown † Clinical Study to Assess the Influence of a Saw Palmetto Preparation in Patients With Benign Prostatic Hyperplasia (BPH) and Sexual Dysfunctions
Condition: Sexual Dysfunctions in Men With Benign Prostatic Hyperplasia
Intervention: Drug: Saw palmetto berry extract
7 Recruiting Safety and Initial Efficacy Study of the Vortx Rx for Treatment of Benign Prostatic Hyperplasia (BPH)
Condition: Benign Prostatic Hyperplasia (BPH)
Intervention: Device: Vortx Rx - Histotripsy BPH Device
8 Recruiting Efficacy and Safety of S-Equol on Men With Benign Prostatic Hyperplasia
Condition: Benign Prostatic Hyperplasia
Interventions: Drug: S-equol;   Drug: Placebo
9 Recruiting Clinical Trial of Safety and Efficiency of Afalaza in Patients With Symptoms of Benign Prostatic Hyperplasia and Risk of Progression
Condition: Benign Prostatic Hyperplasia
Interventions: Drug: Afalaza;   Drug: Placebo
10 Recruiting JALYN for Benign Prostatic Hyperplasia (BPH) and Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS)
Conditions: Benign Prostatic Hyperplasia;   Chronic Prostatitis
Interventions: Drug: Jalyn;   Drug: Placebo
11 Not yet recruiting Comparison of Finasteride and Tamsulosin for Treatment of Benign Prostatic Hyperplasia (BPH) (MK-0906A-149 AM2)
Condition: Benign Prostatic Hyperplasia
Interventions: Drug: Finasteride (MK-906);   Drug: Tamsulosin;   Other: Placebo
12 Recruiting Phase 4 Study of Greenlight XPS Laser Versus BiVAP Saline Vaporization of the Prostate in Men With Symptomatic Benign Prostatic Hyperplasia
Condition: Benign Prostatic Hyperplasia (BPH)
Interventions: Device: Greenlight XPS Laser;   Device: BiVAP Saline Vaporization of the prostate
13 Recruiting A-botulinic Toxin for Symptomatic Benign Prostate Hypertrophy
Condition: Prostatic Hyperplasia
Interventions: Drug: BONT-A intra-prostatic injection;   Drug: Optimized medical BPH treatment
14 Recruiting Effectiveness of onaBoNT-A vs Oral Tamsulosin in Men With Benign Prostatic Hyperplasia and Lower Urinary Track Symptoms (BPH)
Conditions: Benign Prostatic Hyperplasia;   Lower Urinary Track Symptoms
Interventions: Drug: onaBoNT-A + placebo;   Drug: Tamsulosin + placebo
15 Recruiting Phase 3 Evaluation of Re-Injection of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH)(NX02-0022)
Conditions: Benign Prostatic Hyperplasia;   BPH;   Lower Urinary Tract Symptoms (LUTS);   LUTS;   Enlarged Prostate
Intervention: Drug: NX-1207
16 Recruiting Combination Treatment With Doxazosin Plus TolterodineSR 2 mg Versus 4mg in Men With an Overactive Bladder (OAB) and Benign Prostatic Hyperplasia (BPH)
Conditions: Overactive Bladder;   Benign Prostatic Hyperplasia
Intervention: Drug: doxazosin plus tolterodine SR
17 Recruiting Efficacy and Safety of MCS-2 in the Treatment of Lower Urinary Tract Symptoms
Conditions: Lower Urinary Tract Symptoms;   Benign Prostatic Hyperplasia
Interventions: Drug: MCS-2;   Drug: Placebo
18 Recruiting Open-Label Extension Study of MCS-2 in the Treatment of Lower Urinary Tract Symptoms (MCS-2-US-c)
Conditions: Lower Urinary Tract Symptoms;   Benign Prostatic Hyperplasia
Intervention: Drug: MCS-2
19 Recruiting Open-Label Extension Study of MCS-2 in the Treatment of Lower Urinary Tract Symptoms
Conditions: Lower Urinary Tract Symptoms;   Benign Prostatic Hyperplasia
Intervention: Drug: MCS-2
20 Recruiting BPH-6: Comparison of the UroLift System to TURP for Benign Prostatic Hyperplasia
Condition: Benign Prostatic Hyperplasia
Interventions: Device: UroLift(R) System;   Procedure: TURP
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years